Literature DB >> 8924057

Calcium antagonists and endothelial function: focus on nitric oxide and endothelin.

T Godfraind1, S Salomone.   

Abstract

This paper reports on some interactions of calcium antagonists with nitric oxide and endothelin. It reviews evidence showing that the vasorelaxant action of calcium antagonists is facilitated by nitric oxide and describes the mechanism of this modulation. The interaction of calcium antagonists with endothelin is examined considering functions and production of the peptide. Among the functions examined, attention is drawn to the potentiation of responses to vasoconstrictors evoked by low threshold concentrations of endothelin, an action that could be important in pathology. The production of endothelin is increased by a high-salt diet in spontaneous hypertensive stroke-prone rats, this increased production, related to the overexpression of prepro ET-1mRNA, is responsible for cardiovascular hypertrophy and is blunted, in a blood pressure-unrelated manner, by the calcium antagonist lacidipine. At the same dosage regimen, lacidipine inhibits the hypertrophy of the cardiovascular system evoked by a high-salt diet.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8924057     DOI: 10.1007/bf00051108

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  40 in total

Review 1.  Classification of calcium channels and the sites of action of drugs modifying channel function.

Authors:  M Spedding; R Paoletti
Journal:  Pharmacol Rev       Date:  1992-09       Impact factor: 25.468

2.  Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes.

Authors:  H Ito; Y Hirata; M Hiroe; M Tsujino; S Adachi; T Takamoto; M Nitta; K Taniguchi; F Marumo
Journal:  Circ Res       Date:  1991-07       Impact factor: 17.367

3.  Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries. Role of serotonin, thromboxane A2, and adenine nucleotides.

Authors:  D S Houston; J T Shepherd; P M Vanhoutte
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

Review 4.  Calcium channels: molecular pharmacology, structure and regulation.

Authors:  M M Hosey; M Lazdunski
Journal:  J Membr Biol       Date:  1988-09       Impact factor: 1.843

5.  Quantification of two splicing events in the L-type calcium channel alpha-1 subunit of intestinal smooth muscle and other tissues.

Authors:  O Feron; J N Octave; M O Christen; T Godfraind
Journal:  Eur J Biochem       Date:  1994-05-15

6.  Renal endothelin and hypertension.

Authors:  A Hoffman; E Grossman; Z A Abassi; H R Keiser
Journal:  Nature       Date:  1994-11-03       Impact factor: 49.962

7.  Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin-1 gene expression in stroke-prone hypertensive rats.

Authors:  O Feron; S Salomone; T Godfraind
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

8.  Evidence for heterogeneity of endothelin receptor distribution in human coronary artery.

Authors:  T Godfraind
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

9.  Arachidonic acid release and permeability changes induced by endothelins in human cerebromicrovascular endothelium.

Authors:  D B Stanimirovic; N Bertrand; R McCarron; S Uematsu; M Spatz
Journal:  Acta Neurochir Suppl (Wien)       Date:  1994

Review 10.  Calcium antagonists and vasodilatation.

Authors:  T Godfraind
Journal:  Pharmacol Ther       Date:  1994-10       Impact factor: 12.310

View more
  3 in total

Review 1.  Lipophilic calcium antagonists in antiatherosclerotic therapy.

Authors:  S Bellosta; F Bernini
Journal:  Curr Atheroscler Rep       Date:  2000-01       Impact factor: 5.967

Review 2.  Discovery and Development of Calcium Channel Blockers.

Authors:  Théophile Godfraind
Journal:  Front Pharmacol       Date:  2017-05-29       Impact factor: 5.810

3.  Circulating levels of endothelin-1 in a homogenous Gulf Arab population with untreated essential hypertension.

Authors:  Enyioma Obineche; Abdishakur M Abdulle; Awais M Bokhari; Javed Y Yasin; Michael P T Gillett
Journal:  Ann Saudi Med       Date:  2006 Sep-Oct       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.